Intramuscular Testosterone Linked to Rise in Hematocrit
The risk of hematocrit elevation may depend on testosterone therapy’s route of administration, according to investigators.
The risk of hematocrit elevation may depend on testosterone therapy’s route of administration, according to investigators.
Study finds increased risk for severe disease and mortality among men hospitalized with COVID-19 and low testosterone and high estradiol-to-testosterone ratio.
Testosterone levels among adolescents and young men in the United States declined significantly from 1999 to 2016, and data suggest the trend is related to increases in body mass index, a study found.
Higher levels of testosterone are associated with an increased risk of type 2 diabetes in women but play a protective role against type 2 diabetes in men.
Jatenzo® (testosterone undecanoate; Clarus Therapeutics), an oral testosterone replacement therapy, is now available for the treatment of hypogonadism.
Men who followed a low-fat diet showed moderately lower serum testosterone levels than those following nonrestrictive diets, according to results published in Urology.
The American College of Physicians has issued a set of recommendations to clarify the potential benefits and harms of testosterone therapy in men with age-related low testosterone.
For men with and without hypogonadism, testosterone therapy is associated with an increased short-term risk for venous thromboembolism (VTE).
There were increases in rates of new testing, testosterone initiation and initiation without a recent test.
The risk peaks in the first 6 months of hormone treatment, but the overall odds are low.